Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Research Tools and Instruments

McGill University

$112,460.00

High-Performance Liquid Chromatography for DNA Structure Purification and Characterization

EF 2021-22

Résumé
We urgently request a high-performance liquid chromatography (HPLC) instrument to replace our current HPLC system, which is 9 years old and has recently broken down. This has significantly slowed down the research of 20 HQP in my research group, as all the DNA conjugates that we synthesize require HPLC purification and characterization. The requested instrument will support our research program which focuses on developing DNA structures for biological applications. Specifically, this proposal introduces a new, highly scalable method to develop stimuli-responsive DNA hydrogels for tissue regeneration, antimicrobial and biosensing applications. We recently discovered that a small, inexpensive and non-toxic molecule, cyanuric acid, can induce DNA to assemble into a triple helix that grows into long nanofibers. We propose to chemically polymerize adenosine to form poly(adenine) DNA at scale, followed by the addition of cyanuric acid derivatives and crosslinking, to produce biocompatible hydrogels in a single pot with environmentally benign reagents and solvents. We will develop these hydrogels to promote cellular growth, and to respond to multiple biological stimuli through changes in mechanical and drug release properties. In developing the first small molecule-promoted DNA hydrogel, we expand the application space of biocompatible materials: our hydrogels are scalable, mechanically robust, stimuli-responsive, and recyclable, enabling a new, green methodology for the development of DNA hydrogel materials for widespread medical use. Our second project involves the development of sequence-controlled polymers as carriers of nucleic acid therapeutics. We aim to overcome important barriers that prevent their translation to the clinic, such as poor cellular uptake, and entrapment in organelles called endosomes. DNA strands conjugated to sequence-controlled polymers assemble in aqueous media to form monodisperse spherical structures, with a hydrophobic core and a dense nucleic acid corona (spherical nucleic acids, SNAs). We propose to develop these structures are highly effective delivery vehicles, where their nucleic acid exterior silences the expression of disease-causing proteins even in naked form, and can efficiently escape endosomal entrapment. We will also perform high-throughput cell selection studies, using a new class of DNA-encoded polymers developed in our lab. The objective is to select polymers that mediate the escape of nucleic acid therapies from endosomes, and that allow them to operate in the cell cytosol. Overall, the requested HPLC will ensure that productivity in our laboratory is not slowed down, and it will accelerate the discovery of new DNA biomaterials for tissue regeneration and for gene therapy. It will help train HQPs in nucleic acid research, an area that is critically important to ensure Canada's preparedness to any future pandemic.
Programme
Research Tools and Instruments
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RTI-2022-00685
Name nom
Sleiman, Hanadi
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2022
Award amount
112460
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1604
Committee name en
Chemistry (RTI)
Committee name fr
Chimie (OIR)
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Installment
inst:1
Partie
1
Nb partie
1
Application title
High-Performance Liquid Chromatography for DNA Structure Purification and Characterization
Keyword
NSERC
Application summary
We urgently request a high-performance liquid chromatography (HPLC) instrument to replace our current HPLC system, which is 9 years old and has recently broken down. This has significantly slowed down the research of 20 HQP in my research group, as all the DNA conjugates that we synthesize require HPLC purification and characterization. The requested instrument will support our research program which focuses on developing DNA structures for biological applications. Specifically, this proposal introduces a new, highly scalable method to develop stimuli-responsive DNA hydrogels for tissue regeneration, antimicrobial and biosensing applications. We recently discovered that a small, inexpensive and non-toxic molecule, cyanuric acid, can induce DNA to assemble into a triple helix that grows into long nanofibers. We propose to chemically polymerize adenosine to form poly(adenine) DNA at scale, followed by the addition of cyanuric acid derivatives and crosslinking, to produce biocompatible hydrogels in a single pot with environmentally benign reagents and solvents. We will develop these hydrogels to promote cellular growth, and to respond to multiple biological stimuli through changes in mechanical and drug release properties. In developing the first small molecule-promoted DNA hydrogel, we expand the application space of biocompatible materials: our hydrogels are scalable, mechanically robust, stimuli-responsive, and recyclable, enabling a new, green methodology for the development of DNA hydrogel materials for widespread medical use. Our second project involves the development of sequence-controlled polymers as carriers of nucleic acid therapeutics. We aim to overcome important barriers that prevent their translation to the clinic, such as poor cellular uptake, and entrapment in organelles called endosomes. DNA strands conjugated to sequence-controlled polymers assemble in aqueous media to form monodisperse spherical structures, with a hydrophobic core and a dense nucleic acid corona (spherical nucleic acids, SNAs). We propose to develop these structures are highly effective delivery vehicles, where their nucleic acid exterior silences the expression of disease-causing proteins even in naked form, and can efficiently escape endosomal entrapment. We will also perform high-throughput cell selection studies, using a new class of DNA-encoded polymers developed in our lab. The objective is to select polymers that mediate the escape of nucleic acid therapies from endosomes, and that allow them to operate in the cell cytosol. Overall, the requested HPLC will ensure that productivity in our laboratory is not slowed down, and it will accelerate the discovery of new DNA biomaterials for tissue regeneration and for gene therapy. It will help train HQPs in nucleic acid research, an area that is critically important to ensure Canada's preparedness to any future pandemic.